I think the 1st milestone will be to retire the debtand wipe the slate clean. That would be welcome news to shareholders, improve chances of getting uplisted to a major exchange, and offer more leverage in negotiations.
If he's to dilute, that's the way to do it.He could do it with a small fraction of the 100mil share add'n.
Then as he said, he'll finance his R/D with some of that too. And he said he'd do it monthly ...little by little.
Shareholders would welcome that approach ie where dilution goes to the cause of progress.
He spoke of the BLS filing snafu. He made a mistake and corrected it. So give him some slack.
What we know is he and the whole company are working and working tirelessly toward the end goal. That too, along with periodic updates on progress is comforting to know. ..ie not being left hanging
Yes- He spoke softly about the FDA. I picked that up too. It was wise that he did with so much depending on what the FDA decides.
I like the guy for the reasons offered in an earlier post . He presented himself as a leader whose directing a charterd course to a good result.
I'll be back in soon.
And to answer the cynical poster- I use both Techical Analysis and depend on Research reports by professionals. I know little about the science. But I won't give much credit to unpaid promotors who own shares
like some I read.
Market Data 
Markets 
AI
